Longboard Pharmaceuticals Inc (NAS:LBPH)
$ 34.785 1.385 (4.15%) Market Cap: 1.35 Bil Enterprise Value: 999.79 Mil PE Ratio: 0 PB Ratio: 4.59 GF Score: 36/100

Longboard Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript

Jun 15, 2022 / 07:00PM GMT
Release Date Price: $4.2 (-1.18%)
Unidentified Analyst

Back to the JMP Life Sciences Conference. It's my pleasure to introduce Longboard Pharmaceuticals with the CEO, Kevin Lind, giving the presentation. Thank you very much for joining us today.

Kevin Lind
Longboard Pharmaceuticals, Inc. - President, CEO, and Director

Thank you.

So, thank you to JMP for having us here today. It's been a couple of years since I was last at a JMP Conference. Just a reminder, we'll be making forward-looking statements. Please check our SEC filings for the latest information, and we will be -- our actuals may vary from what we are predicting.

As I said, it's been a couple of years for me since I was at a JMP Conference. We had a great relationship with JMP when we -- I was at Arena. And three years ago, we spun Arena -- Longboard Pharmaceuticals out of Arena.

And the story, the thesis, the strategy behind Longboard is really the story, thesis, strategy behind Arena, which is take some phenomenal molecules that have differentiated PK/PD target engagement, pick the right indications, and move

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot